Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

TAP PHARMACEUTICALS INC — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Termination

TAP PHARMACEUTICALS INC

via MR. MICHAEL STRATTON

2nd Quarter (Apr 1 - June 30) · 2008Posted Jun 9, 2008Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: TAP PHARMACEUTICALS INC
Description: pharmaceuticals
Location: Maryland · United States of America

Registrant

Firm: MR. MICHAEL STRATTON
Description: public relations
Location: Denver, Colorado, United States of America

Lobbying activities

1 issue

Health Issues
Medicare Policy
LobbyistsMICHAEL STRATTON
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.